One of the most exciting developments is the growth of immune-based therapies. CAR-T cell therapies involve modifying a ...

A joint statement issued by the United States and 15 other countries touts the technology’s potential for accelerating ...

New research suggests that an unexpected animal, the veiled chameleon, may offer scientists a new model for studying human ...

The following expert commentary can be used by journalists and media organizations in their own publications and news ...

While biotech increasingly adopts AI for R&D, manufacturing bottlenecks constrain health innovation. AI and robotics have the ...

Our natural sciences interdisciplinary master’s program is distinct from other biomedical master’s programs in the Jacobs School. While those programs are geared toward students looking for a focused ...

Students at Bermuda College can now complete the first year of an electrical engineering pathway on the island. The move ...

Kirstyn Hill has worked as a clinical pediatric and women’s health pharmacist since 2020. She was driven to work with a patient population that is not often able to easily speak up for themselves and ...

AI agents don’t go rogue. That’s something only humans do. Nevertheless, a New York Times article – representative of much ...

Anvi Palav founded BioMedizone at 15 to bring biomedical research access to students in underserved communities.

Open benchmark tests whether AI can reason across aging biology – and finds specialist models can outperform far larger systems.

In the latest trading session, Gilead Sciences (GILD) closed at $149.45, marking a -1.21% move from the previous day.